Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Teyi Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company that focuses on the development, production, and sale of a broad range of medicinal products within China. Its offerings include both proprietary traditional Chinese medicines (TCMs) and various chemical products, such as finished preparations, raw materials, and other related chemical compounds. The company's portfolio of finished drugs targets several key therapeutic areas, including respiratory conditions (like cough and phlegm), kidney-related ailments, infectious diseases, cardiovascular issues, and digestive system disorders. Beyond finished medications, Teyi Pharmaceutical also supplies a variety of chemical raw materials and products; notable examples include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth and citric acid series compounds, and zinc sulfate. Based in Taishan, China, the company underwent a name change in November 2016, transitioning from its previous identity as Guangdong Taicheng Pharmaceutical Co., Ltd. to its current name, Teyi Pharmaceutical Group Co., Ltd.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,